FDA Investigating Serious Risk of T-cell Malignancy Following BCMA-Directed or CD19-Directed Autologous Chimeric Antigen Receptor (CAR) T cell Immunotherapies | FDA - discu.eu

Linking pages

FDA says cancer treatment CAR-T therapy may increase risk of cancer https://www.nbcnews.com/health/cancer/fda-says-cancer-treatment-car-t-therapy-may-increase-risk-cancer-rcna135262 116 comments
CAR-T, Lifesaving Cancer Treatment, May Sometimes Cause Cancer, FDA Says - The New York Times https://www.nytimes.com/2023/11/28/health/fda-car-t-blood-cancer.html 1 comment

Related searches:

Search whole site: site:www.fda.gov

Search title: FDA Investigating Serious Risk of T-cell Malignancy Following BCMA-Directed or CD19-Directed Autologous Chimeric Antigen Receptor (CAR) T cell Immunotherapies | FDA

See how to search.

Submit link to: